ConductScience.org, home

Paper9831300

The United Kingdom Prospective Diabetes Study (UKPDS) implications for the pharmacotherapy of type 2 diabetes mellitus.

Bretzel RG and 2 others. Exp Clin Endocrinol Diabetes, 1998. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. The United Kingdom Prospective Diabetes Study (UKPDS) implications for the pharmacotherapy of type 2 diabetes mellitus. Papers, record 9831300. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9831300

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The United Kingdom Prospective Diabetes Study (UKPDS) implications for the pharmacotherapy of type 2 diabetes mellitus.
PubMed
Journal
Exp Clin Endocrinol Diabetes
PubMed
Year
1998
PubMed
Publication types
Editorial, Review
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
0.88
iCite
Revised in PubMed
2026-01-28
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bretzel RGR G
2Voigt KK
3Schatz HH

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Blood Glucose
Blood Pressure
Glycated Hemoglobin
Humans
Multicenter Studies as Topic
Prospective Studies
Randomized Controlled Trials as Topic
United Kingdom

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
40512624VDAC1 is a target for pharmacologically induced insulin hypersecretion in β cells.Cell Rep2025https://conductscience.org/library/papers/40512624PubMed
37627476Poplar Propolis Improves Insulin Homeostasis in Non-Diabetic Insulin-Resistant Volunteers with Obesity: A Crossover Randomized Controlled Trial.Antioxidants (Basel)2023https://conductscience.org/library/papers/37627476PubMed
36762135Prescribing exercise and physical activity to treat and manage health conditions.Ulster Med J2023https://conductscience.org/library/papers/36762135PubMed
35196393ATP-Sensitive Potassium Channels in Hyperinsulinism and Type 2 Diabetes: Inconvenient Paradox or New Paradigm?Diabetes2022https://conductscience.org/library/papers/35196393PubMed
33317096Investigation of the Phytochemical Composition, Antioxidant Activity, and Methylglyoxal Trapping Effect of Galega officinalis L. Herb In Vitro.Molecules2020https://conductscience.org/library/papers/33317096PubMed
24678614Treatment of mild and moderate type-2 diabetes: open prospective trial with Hintonia latiflora extract.Eur J Med Res2014https://conductscience.org/library/papers/24678614PubMed
21779144Patient perceptions of treatment and illness when prescribed multiple medicines for co-morbid type 2 diabetes.Diabetes Metab Syndr Obes2011https://conductscience.org/library/papers/21779144PubMed
19684847Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results.Arch Drug Inf2009https://conductscience.org/library/papers/19684847PubMed
18959471Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.PLoS Med2008https://conductscience.org/library/papers/18959471PubMed
10776834Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus.Drugs2000https://conductscience.org/library/papers/10776834PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9831300

GET https://conductscience.org/api/papers/v1/9831300/authors